Consists of human and animal health professionals, as well as academics and researchers from around the globe to progress One Medicine
Humanimal Trust has formed a science committee that will look at grant applications and suggest projects to be funded in Humanimal Trustpriority areas, which support One Medicine. Through this approach, humans and animals benefit from sustainable and equal medical advances, but not at the expense of an animal’s life.1
In an interview with the chair of trustees at Humanimal Trust and interim chair of the science committee,2 Roberto La Ragione, BSc, MSc, PhD, FRSB, CBiol, FIBMS, CSci, AECVM, FRCPath, HonAssocRCVS, professor at the University of Surrey in Guildford, England, explained that education is critical to One Medicine and by discovering health similarities in animals and humans helps drive change. “We know that One Medicine has transformative potential across all areas of medicine where physiological and genetic similarities exist between humans and animals,” said La Ragione, in an organizational release.1
Funds provided by Humanimal Trust will first focus on smaller projects (eg, proof of concept, contributions to existing PhD studies, Masters projects and research studies under £20k—or about $24,000 USD) that are within the charity’s priority areas. The goal is to support partnership among veterinarians, doctors, researchers, nurses and allied professionals. With time, larger projects may also be considered for funding.1
“Research that the Trust has previously funded has the potential to help improve the lives of both humans and animals with similar conditions, and with their combined professional experience, expertise and passion for One Medicine, our new science committee will ensure that we are on the right path to developing further evidence that a collaborative, One Medicine approach can benefit all patients, regardless of their species,” La Ragione added. “On behalf of all Humanimal Trust trustees, staff, volunteers and supporters, I would like to welcome all new members of our science committee and I look forward to working with them.”
Members of Humanimal Trust’s science committee include1:
“We feel extremely fortunate to have such a passionate and forward-thinking group of people from the worlds of both human and animal health on our science committee,” said Joe Bailey, CEO of Humanimal Trust.1 “Together, we will ensure that the research we fund, facilitate and share has reciprocity at its core, so that not only do practitioners and allied researchers benefit from medical advances, but also patients, regardless of their species.”
“By sharing knowledge gained through treating naturally occurring diseases in both human and animal patients to inform medical research and utilizing non-animal research technology to further veterinary as well as human medicine, we truly believe that the use of animals in research can be significantly reduced until one day, experimental animal use becomes obsolete,” she added.
References